Pulse Biosciences Announces Receipt of MDSAP Certification
(World News Science)

Achieving ISO-13485:2016 MDSAP Certification Affirms the Company`s Quality Management Systems Meet FDA, Health Canada and CE Mark Requirements HAYWARD, Calif.--(BUSINESS WIRE)--Sep. 29, 2020-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulationâ"¢ (NPSâ"¢) technology, today announced the receipt of Medical Device Single Audit Program certification. The Medical Device Single Audit Program (MDSAP) allows the conduct of a single regulatory audit of a medical device manufacturer`s quality management system to satisfy the requirements of multiple regulatory jurisdictions or authorities to enable appropriate regulatory oversight...